2-[1-[1-(4,4-difluorocyclohexyl)indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide
C26H28F2N4O2 — CID 155225001
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1-[1-(4,4-difluorocyclohexyl)indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide
2-[1-[1-(4,4-difluorocyclohexyl)indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide (PubChem CID 155225001) has the molecular formula C26H28F2N4O2 and a molecular weight of 466.53 g/mol. Its IUPAC name is 2-[1-[1-(4,4-difluorocyclohexyl)indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide.
Molecular Properties
| Compound Name | 2-[1-[1-(4,4-difluorocyclohexyl)indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide |
|---|---|
| PubChem CID | 155225001 |
| Molecular Formula | C26H28F2N4O2 |
| Molecular Weight | 466.53 g/mol |
| Exact Mass | 466.22 |
| IUPAC Name | 2-[1-[1-(4,4-difluorocyclohexyl)indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide |
| SMILES | CC(C(N)=O)C1CC(=O)N(c2ccc3c(cnn3C3CCC(F)(F)CC3)c2)C1c1ccccc1 |
| InChI | InChI=1S/C26H28F2N4O2/c1-16(25(29)34)21-14-23(33)31(24(21)17-5-3-2-4-6-17)20-7-8-22-18(13-20)15-30-32(22)19-9-11-26(27,28)12-10-19/h2-8,13,15-16,19,21,24H,9-12,14H2,1H3,(H2,29,34) |
| InChIKey | XFOQLGLBKUMHNP-UHFFFAOYSA-N |
| XLogP | 5.00 |
| TPSA | 81.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.53 |
| LogP ≤ 5 | 5.00 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155225001 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.